Immune thrombocytopenia (itp) Clinical Trials

Delta Trials catalogs 30 clinical trials for Immune thrombocytopenia (itp) in its publicly accessible dataset. Within this set, 16 currently recruiting participants and 6 trials have reached completion. This research occurs across 153 participating sites around the world. An additional 8 trials are in other active phases such as not yet recruiting or pending status. Since 2020, 2 trials were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.